Fractional exhaled Nitric Oxide (FeNO) level as a predictor of COVID-19 disease severity

OBJECTIVE: To assess the feasibility of Fractional exhaled Nitric Oxide (FeNO) as a simple, non-invasive, cost-effective and portable biomarker and decision support tool for risk stratification of COVID-19 patients. METHODS: We conducted a single-center prospective cohort study of COVID-19 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lior, Yotam, Yatzkan, Noga, Brami, Ido, Yogev, Yuval, Riff, Reut, Hekselman, Idan, Fremder, Moran, Freixo-Lima, Gabriella, Be'er, Moria, Amirav, Israel, Lavie, Moran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116042/
https://www.ncbi.nlm.nih.gov/pubmed/35597408
http://dx.doi.org/10.1016/j.niox.2022.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116042/
https://www.ncbi.nlm.nih.gov/pubmed/35597408
http://dx.doi.org/10.1016/j.niox.2022.05.002

Ejemplares similares